Summit Therapeutics plc

Director, Portfolio Strategy

Summit Therapeutics plc$200K — $250K *
Pharmaceuticals & Biotech
8 - 10 years of experience
Job Overview by Ladders

Qualifications

  • Bachelor's degree in Biotech or related field; advanced degree preferred
  • 10+ years pharmaceutical/biotech experience in oncology with a focus on market research
  • Strong grasp of Solid Tumor Oncology landscape and therapeutic areas
  • Proficiency in developing market research and analysis
  • Experience with patient-based forecasting and NPV modeling
  • Excellent communication and presentation skills
  • Ability to travel up to 25% as necessary.

Responsibilities

  • Lead New Indication strategy for Oncology, collaborating across functions
  • Develop framework for overall portfolio strategy and decision-making support
  • Deliver strategic insights from market research and competitive analysis
  • Create integrated strategy for new solid tumor indications in partnership with various teams
  • Provide strategic guidance on business development opportunities
  • Conduct deep competitor analysis and real-time market trend assessments
  • Execute market research plans, ensuring quality and timely deliverables.

Benefits

  • Comprehensive health coverage
  • Generous paid time off policy
  • 401(k) retirement plan with company match
  • Professional development opportunities
  • Collaborative work environment focused on innovation.
Full Job Description
Overview of Role:

The Director, Portfolio Strategy position reports to the Executive Director, Portfolio Strategy and Competitive Intelligence to support strategic planning activities by providing actionable recommendations based on assessments of markets and competitors, both existing and potential.

Role and Responsibilities:
  • Lead and drive New Indication strategy and planning in several Oncology indications, working cross-functionally (e.g. Clinical, Regulatory, Commercial) to guide Summit's portfolio for late-stage clinical development strategy
  • Develop/refine framework and process for the New indication and overall portfolio strategy, providing thought leadership and supporting key strategic decision-making and investment decisions
  • Deliver strategic market and competitive intelligence insights through research, scenario planning, and impact assessments to guide executive decision-making and Summit's portfolio strategy.
  • Deliver Disease Area strategy for new solid tumor indications by providing an overall integrated strategy and market assessment in partnership with R&D, Clinical, Medical, Commercial and Program teams
  • Partner with BD team to provide strategic direction and guidance on business development opportunities
  • Conduct deep analysis of competitors, products, and market trends, maintaining real-time awareness of landscape changes and translating insights into strategic implications for launch and also for pipeline indications
  • Develop, lead and execute comprehensive market research plans (qualitative, quantitative, and competitive), selecting vendors, designing studies, interpreting results, and ensuring timely, high-quality deliverables.
  • Develop NPV, forecasting and revenue modeling for new indications up to 18 months before launch, providing data-driven assumptions for early commercial planning.
  • Lead TPP development and alignment with cross-functional team for several solid tumor indications
  • Integrate market research and competitive intelligence into strategic planning, including brand plans, market access, and situation analysis.
  • Maintain an in-depth understanding of oncology markets and data sources, synthesizing findings into a central knowledge repository for organizational use.
  • Provide ad hoc analytical support to executive stakeholders to inform R&D, commercial, and business development decisions.
  • Leverage best-in-class analytical methodologies and tools to interpret epidemiology, market, and customer data into actionable recommendations.
  • Build and manage external partnerships-from market research vendors to data providers-ensuring quality, accountability, and cost-effectiveness.


Experience, Education and Specialized Knowledge and Skills:
  • Bachelors degree in Biotech or related field; advanced degree (MS, PhD) preferred.
  • Minimum of 10+ years of pharmaceuticals/biotech industry experience working with both qualitative and quantitative research in oncology/pharma market with emphasis on Non-Small Cell Lung cancer and other Solid Tumors is required.
  • Strong understanding of the Solid Tumor Oncology landscape, including portfolio strategy, market planning, competitive intelligence, forecasting and key therapeutic areas such as lung cancer and colorectal cancer.
  • Proven ability to identify and collect relevant market, customer, and competitor data; perform quantitative and qualitative analysis;
  • Ability to translate complex findings into actionable market insights and strategic recommendations.
  • Experience developing and executing primary and secondary market research, with exposure to global markets preferred.
  • Proven experience leading, managing and executing end-to-end market research: designing research plans, synthesizing findings/insights, presenting, etc.
  • Experience with advanced spreadsheets, patient-based forecast modeling including dynamic patient models, NPV modeling.
  • Experience in facilitating competitive workshops, well-versed in TPP development with program and study teams is a plus.
  • Use online market research and catalogue findings to databases.
  • Strong communication and presentation skills.
  • Skilled at PowerPoint, Excel and similar data tools.
  • Ability to travel up to 25% of the time, depending on business needs.


This is the pay for this position

Pay Transparency

$200,000-$250,000 USD

Actual compensation packages are based on several factors that are unique to each candidate, including but not limited to skill set, depth of experience, certifications, and specific work location. This may be different in other locations due to differences in the cost of labor. The total compensation package for this position may also include bonus, stock, benefits and/or other applicable variable compensation.

Summit does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact Summit's Talent Acquisition team at [redacted] to obtain prior written authorization before referring any candidates to Summit.

About Summit Therapeutics plc

Summit Therapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of novel medicines to treat rare diseases with high unmet medical need. The company's lead product candidate, Ridinilazole, is a precision antibiotic that has the potential to treat Clostridium difficile infection (CDI) with a superior clinical profile compared to existing CDI treatments. Summit Therapeutics is also developing a pipeline of additional product candidates targeting genetic diseases and other indications.
Learn more about Summit Therapeutics plc
Size
105 employees
Market Cap
$842.6 million
Industry
Founded
2003
5 Year Trend
+9910%
Revenue
$1 million
NASDAQ

Similar Jobs

More Jobs at Summit Therapeutics plc

More Pharmaceuticals & Biotech Jobs

Find similar Director, Portfolio Strategy jobs: